Rehabilitation Gaming System for Cerebral Palsy

Not Applicable

Completed

• Conditions: Cerebral Palsy; Movement Disorder
• Interventions: Behavioral: VR-based motor training; Behavioral: Conventional Therapy

• Registration Number: NCT02938754
• Lead Sponsor: Universitat Pompeu Fabra

Brief Summary

In this study the investigators evaluate the effectivity of Virtual Reality-based rehabilitation protocols for preventing motor deterioration in patients with cerebral palsy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-06-22
• Study First Submitted QC: 2016-10-18
• Study First Posted: 2016-10-19
• Study Start: 2016-11
• Primary Completion: 2018-05
• Study Completion: 2018-05
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-01
• Last Update Posted: 2018-11-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

• Children and Adult patients between 12- 50 years old diagnosed with CP according to Gross Motor Function Classification System (GMFCS). Level of disability between I and IV.
• Ashworth modified clinical scale < 3 (Ashworth, 1964, Bohannon Bohannon and Smith, 1987).

Exclusion Criteria

• Severe visual impairment.
• Severe cognitive impairment such as mental retardation which impedes the understanding of the task.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
VR-based motor training	VR-based motor training	Subjects will perform 3 different training protocols in Virtual Reality that imply performing tasks of vertical and planar reaching and hitting spheres, or hockey pucks, spaced at different time, speed and color.
Conventional Therapy	Conventional Therapy	Subjects will perform conventional rehabilitation tasks for the upper-extremities that imply vertical and planar reaching movements.

Primary Outcome Measures

Name	Time	Method
Change in motor function of the affected extremity as measured by MACS clinical scale	Change from Baseline to week 5 (End of Treatment)

Secondary Outcome Measures

Name	Time	Method
Change in motor function of the affected extremity as measured by the Box and Blocks clinical scale	Change from Baseline to week 5 (End of Treatment)
Change in the amount of use of the affected arm during training as measured by the Virtual Reality system	Change from Baseline to week 5 (End of Treatment)
Change in attention and visuo-perceptive and visuo-constructional apraxia as measured by the WAIS-III scale	Change from Baseline to week 5 (End of Treatment)

Trial Locations

Locations (1)

Universitat Pompeu Fabra; 🇪🇸 Barcelona, Spain